New Key Statistics Module, Z-Score and F-Score
SZSE:300039 Key Ratios
Market Cap ¥ M | 6,464.28 |
Enterprise Value ¥ M | 5,375.09 |
P/E(ttm) | 18.50 |
PE Ratio without NRI | 18.07 |
Forward PE Ratio | -- |
Price/Book | 1.68 |
Price/Sales | 4.14 |
Price/Free Cash Flow | 32.02 |
Price/Owner Earnings | 21.38 |
Payout Ratio % | 0.29 |
Revenue (TTM) ¥ M | 1,560.00 |
EPS (TTM) ¥ | 0.33 |
Beneish M-Score | -2.73 |
10-y EBITDA Growth Rate % | -4.70 |
5-y EBITDA Growth Rate % | -0.10 |
y-y EBITDA Growth Rate % | 24.30 |
EV-to-EBIT | 13.97 |
EV-to-EBITDA | 13.97 |
PEG | -- |
Shares Outstanding M | 1,046.00 |
Net Margin (%) | 22.35 |
Operating Margin % | 22.32 |
Pre-tax Margin (%) | 25.71 |
Quick Ratio | 5.77 |
Current Ratio | 6.36 |
ROA % (ttm) | 8.09 |
ROE % (ttm) | 9.18 |
ROIC % (ttm) | 9.75 |
Dividend Yield % | 1.56 |
Altman Z-Score | 10.36 |
SZSE:300039 Number of Guru Trades
SZSE:300039 Volume of Guru Trades
Gurus Latest Trades with SZSE:300039
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300039 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Kaibao Pharmaceutical Co Ltd Insider Transactions
No Available Data